Acción IOVANCE BIOTHERAPEUTICS INC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Iovance Biotherapeutics Inc Nasdaq

Acciones

US53619R1023

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
Iovance Biotherapeutics : 2022 Annual Report
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Small lymphocytic lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates
Iovance Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours
Iovance Biotherapeutics: Q1 Earnings Snapshot
Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q1 Revenue $715,000
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - April 19, 2024
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción IOVA
  4. Acción
  5. Noticias Iovance Biotherapeutics Inc
  6. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA